United States · FDA National Drug Code directory

Obagi Skintrinsiq Clarifiying Protocol

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62032-909_a9c17c57-a3af-43d6-9db3-56fb8e28894b
Product NDC: 62032-909
Form: KIT
Composition / generic term: salicylic acid, titanium dioxide, and zinc oxide
Labeler: Obagi Cosmeceuticals LLC
Marketing category: OTC MONOGRAPH DRUG
Marketing start / end (source format): 20210801
Source listing expiry: 20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

1 KIT in 1 BOX (62032-909-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC · 62032-909-09

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →